Site Map

• Home
• RITUXAN Indications
  • Redefining Outcomes in NHL Therapy
  • Diffuse Large B-cell NHL (DLBCL)
    • LNH 98-5 (GELA) NHL Trial
    • E4494 (NCI) NHL Trial
    • MInT Trial
  • Previously Untreated Follicular NHL in Combination with CVP
  • Non-progressing Low-grade NHL After CVP
  • Relapsed/Refractory Low-grade or Follicular NHL
    • Retreatment Trial
    • Weekly x4 Trial
    • Weekly x8 Trial
    • Bulky Disease Trial
• NHL Dosing and Administration
• Proposed Mechanism of Action
• Professional Resources
  • Reimbursement, Access, and Support
  • Patient Materials
  • Oncologist and Pharmacist Resources
  • Nurse and Pharmacist Resources
  • Key Publications and Reprints
  • Links and Additional Resources
    • ASH & ASCO
    • NHL Classifications
    • NHL Staging
    • Links
• Important Safety Information
• E-mail Registration
• Full Prescribing Information
• Rituxan for RA
• Privacy Policy
• Terms
• Copyright
• Medication Guide